If the institutions aren't trying to push the price lower to screw over the folks holding options - what will happen to the price. My guess is if they are going to try and write another batch of options they are not going to do it at this level - if I were a betting man I would say we may see a spike to $4.50 to $5 so a batch of options can be written and then the price will sag back again (but I believe we will not be seeing 2s again).
What will 2013 bring? PPS catalysts won't just be EU approval, but also may be a marketing alliance in Europe, surprising sales growth in US, off-label use reports from physicians, (broad applicability) effectiveness reported in new areas from patients and doctors (which sparks drug sales), additional prominent endorsements, upgrades (which sparks share sales), institutional or hedge fund purchases (short squeeze), insider buying, completed enrollment or top line data from each of the clinicals, another outside study, hints of an acquisition from a big player showing up in the options market just to mention a few things that will happen this year. One announcement from a major hedge fund buying up shares and we could double.... it is just a matter of time.
I agree, there are so many positives it is just a matter of time. If I have to hold this stock for another 3 or 4 years it will be worth it. I just keep buying and accumulating - eventually this will be bought by a big pharma. I do not believe this is a $3 stock anymore - in the next 3 to 6 months we will see the next move up (probably in the $4.5 to $5.50 range).